Peptic Ulcer Drugs Market Growth, Demand and Challenges of the Key Industry Players 2024-32

1
Global Peptic Ulcer Drugs Market Research and
Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Peptic Ulcer Drugs Market Global
  Industry Trends, Share, Size, Growth, Opportunity
  and Forecast 2024-2032," the global peptic ulcer
  drugs market size reached US 4.8 Billion in
  2023.
• A peptic ulcer is an open sore that develops in
  the lining of the stomach that is caused due to
  inflammation, radiation therapy, frequent oral
  and injectable administration of aspirins, and
  anti-inflammatory drugs. It is associated with
  abdominal pain, discomfort, nausea, vomiting,
  weight loss, bloating, belching, and loss of
  appetite.
• It is diagnosed through a combination of medical
  history, physical examination, and diagnostic
  tests, such as endoscopy, blood and stool tests,
  and biopsy. It is treated using medications and
  drugs, such as antibiotics, proton pump
  inhibitors (PPI), H2 antagonists, antacids,
  potassium-competitive acid blockers (P-CAB), and
  ulcer protectives, which aid in reducing the body
  aches, minimizing acid secretion, and protecting
  the stomach from digestive juices.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/peptic-ulcer-drugs-mark
  et/requestsample

4
Report Description

• Global Peptic Ulcer Drugs Market Trends
• The surging prevalence of peptic ulcers and the
  growing geriatric population that is susceptible
  to developing these medical disorders represent
  one of the major factors driving the demand for
  peptic ulcer drugs and treatment around the
  world. Moreover, the rising number of individuals
  suffering from obesity, unhealthy lifestyle
  habits, and increasing instances of stomach
  cancer are some of the other factors favoring the
  growth of the market. In addition, governments of
  numerous countries are initiating campaigns to
  spread awareness about the benefits of early
  diagnosis of the disease.
• This, coupled with the expanding number of
  clinical studies and trials to develop new
  treatments for peptic ulcers, is contributing to
  the market growth. Apart from this, the easy
  availability of various generic drugs for
  treating and preventing stomach and intestinal
  ulcers and gastroesophageal reflux disease (GERD)
  via offline and online retail channels is
  strengthening the growth of the market. Besides
  this, significant improvements in the healthcare
  infrastructure and diagnostic technologies are
  creating a positive outlook for the market.
• Looking forward, the market is anticipated to
  reach a value of US 6.1 Billion by 2032,
  exhibiting a CAGR of 2.65 during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/peptic-ulcer-drugs-mark
  et

5
Report Segmentation

• Product Type Insights
• Proton Pump Inhibitors
• Potassium-Competitive Acid Blocker (P-CAB)
• Antacids
• H2-Antagonists
• Antibiotics
• Ulcer protective
• Ulcer Type Insights
• Gastric Ulcer
• Duodenal Ulcer
• Others
• Distribution Channel Insights
• Hospital Pharmacies

6
Report Segmentation

• Retail Pharmacies
• Online Pharmacies
• Regional Insights
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Abbott Laboratories
• AstraZeneca plc
• Boehringer Ingelheim International GmbH
• Novitium Pharma LLC
• Pfizer Inc.
• PharmaKing Co. Ltd.
• RedHill Biopharma Ltd
• Viatris Inc.
• Yuhan Corporation
• Zydus Lifesciences Limited

8
Key Questions Answered in the Report
9
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Peptic Ulcer Drugs
  Market    5.1    Market Overview    5.2  
   Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Product Type    6.1  
   Proton Pump Inhibitors        6.1.1 Market
  Trends        6.1.2 Market Forecast    6.2  
   Potassium-Competitive Acid Blocker (P-CAB)     
    6.2.1 Market Trends        6.2.2 Market
  Forecast    6.3    Antacids        6.3.1 Market
  Trends        6.3.2 Market Forecast       

10
Table of Contents

•     6.4    H2-Antagonists        6.4.1 Market
  Trends        6.4.2 Market Forecast    6.5  
   Antibiotics        6.5.1 Market Trends       
  6.5.2 Market Forecast    6.6    Ulcer
  Protective        6.6.1 Market Trends       
  6.6.2 Market Forecast7    Market Breakup by
  Ulcer Type    7.1    Gastric Ulcer        7.1.1
  Market Trends        7.1.2 Market Forecast   
  7.2    Duodenal Ulcer        7.2.1 Market
  Trends        7.2.2 Market Forecast    7.3  
   Others        7.3.1 Market Trends        7.3.2
  Market Forecast8    Market Breakup by
  Distribution Channel    8.1    Hospital
  Pharmacies        8.1.1 Market Trends       
  8.1.2 Market Forecast    8.2    Retail
  Pharmacies        8.2.1 Market Trends       
  8.2.2 Market Forecast    8.3    Online
  Pharmacies        8.3.1 Market Trends       
  8.3.2 Market Forecast
• For more information, visit https//www.imarcgrou
  p.com/peptic-ulcer-drugs-market/toc

11
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

12
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com